German flavour and fragrance company Symrise has introduced Cellexora MD, a plant-derived cosmetic ingredient positioned for skin regeneration and longevity-focused skincare applications. The ingredient is developed from upcycled organic apple side streams sourced in Italy and is aligned with growing industry demand for sustainable biotechnology actives.
According to Symrise, Cellexora MD is produced using 100% plant-derived content in accordance with ISO 16128-2 natural origin guidelines. The launch reflects increasing market interest in exosome-inspired cosmetic ingredients and extracellular vesicle technologies designed to support advanced anti-ageing and regenerative skincare formulations.
The ingredient is based on extracellular vesicles derived from botanical sources and is intended to support biological communication pathways linked to skin repair, resilience, and vitality. Symrise states that Cellexora MD enables skincare manufacturers to move beyond surface-level correction by targeting mechanisms associated with long-term skin health and regeneration.
The reported INCI composition includes Maltodextrin and Malus domestica fruit vesicles. Cellexora MD is supplied as a white, odourless powder with high water solubility, allowing easier integration into a broad range of formulation systems including serums, emulsions, essences, hydrogel products, and leave-on treatments.
Symrise indicates that the ingredient interacts with keratinocytes, fibroblasts, and macrophages through extracellular vesicle-mediated signalling pathways. These interactions are associated with collagen production and improvements in skin firmness, elasticity, and resilience.
The company further claims that the ingredient supports soothing pathways that help maintain balanced skin conditions under environmental stress. According to Symrise, clinical observations demonstrated visible reductions in wrinkle length, depth, and volume within 30 days of application, although independent peer-reviewed clinical publication details were not disclosed in the source material.
For OEM manufacturers, formulation teams, and private-label operators, Cellexora MD may present opportunities within premium anti-ageing skincare, regenerative skincare concepts, and longevity-focused dermocosmetic products. The ingredient’s water solubility and powder format may also provide advantages in formulation flexibility, transportation efficiency, and storage stability.
A key differentiator for Cellexora MD is its sustainability positioning. By utilizing upcycled apple side streams, the ingredient aligns with broader industry initiatives focused on circular raw material sourcing and waste reduction. Upcycled cosmetic actives continue to gain commercial relevance among manufacturers targeting ESG-driven product development and export-oriented natural skincare markets.
The launch also highlights the continued convergence of biotechnology, sustainability, and skin longevity trends within the global cosmetic ingredient sector. However, manufacturers adopting exosome-positioned ingredients should carefully evaluate claims substantiation, formulation stability, regulatory positioning, and jurisdiction-specific compliance requirements before commercialization.